These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32780957)

  • 1. New Insights into Pheochromocytoma Biology: the Role of the Insulin - Like Growth Factor 1 (IGF1) System.
    Pennisi PA; Fernández MC; Martin A
    Pediatr Endocrinol Rev; 2020 Aug; 17(4):331-342. PubMed ID: 32780957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
    de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
    Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.
    Eid M; Foukal J; Sochorová D; Tuček Š; Starý K; Kala Z; Mayer J; Němeček R; Trna J; Kunovský L
    Cancer Med; 2023 Jul; 12(13):13942-13957. PubMed ID: 37145019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.
    Welander J; Söderkvist P; Gimm O
    Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings.
    Aygun N; Uludag M
    Sisli Etfal Hastan Tip Bul; 2020; 54(2):159-168. PubMed ID: 32617052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.
    Gimm O; DeMicco C; Perren A; Giammarile F; Walz MK; Brunaud L
    Langenbecks Arch Surg; 2012 Feb; 397(2):155-77. PubMed ID: 22124609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism.
    Tevosian SG; Ghayee HK
    J Clin Endocrinol Metab; 2018 May; 103(5):1779-1789. PubMed ID: 29409060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genomic landscape of phaeochromocytoma.
    Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW
    J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas.
    Oudijk L; van Nederveen F; Badoual C; Tissier F; Tischler AS; Smid M; Gaal J; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger R; Favier J
    PLoS One; 2015; 10(3):e0121361. PubMed ID: 25794004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.
    Lowery AJ; Walsh S; McDermott EW; Prichard RS
    Oncologist; 2013; 18(4):391-407. PubMed ID: 23576482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of paragangliomas.
    Corssmit EP; Romijn JA
    Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma.
    Miyauchi M; Akashi T; Furukawa A; Uchida K; Tamura T; Ando N; Kirimura S; Shintaku H; Yamamoto K; Ito T; Miura K; Kayamori K; Ariizumi Y; Asakage T; Kudo A; Tanabe M; Fujii Y; Ishibashi H; Okubo K; Murakami M; Yamada T; Takemoto A; Bae Y; Eishi Y; Ohashi K
    Endocr Pathol; 2022 Dec; 33(4):506-518. PubMed ID: 36029394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
    Gimenez-Roqueplo AP; Dahia PL; Robledo M
    Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes.
    Turin CG; Crenshaw MM; Fishbein L
    Endocr Oncol; 2022 Jan; 2(1):R65-R77. PubMed ID: 37435466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and imaging of pheochromocytomas and paragangliomas: current update.
    Katabathina VS; Rajebi H; Chen M; Restrepo CS; Salman U; Vikram R; Menias CO; Prasad SR
    Abdom Radiol (NY); 2020 Apr; 45(4):928-944. PubMed ID: 31069476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
    Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
    J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging.
    Alrezk R; Suarez A; Tena I; Pacak K
    Front Endocrinol (Lausanne); 2018; 9():515. PubMed ID: 30538672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
    Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
    Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stem Cells in Pheochromocytoma and Paraganglioma.
    Scriba LD; Bornstein SR; Santambrogio A; Mueller G; Huebner A; Hauer J; Schedl A; Wielockx B; Eisenhofer G; Andoniadou CL; Steenblock C
    Front Endocrinol (Lausanne); 2020; 11():79. PubMed ID: 32158431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma.
    Ferrara AM; Lombardi G; Pambuku A; Meringolo D; Bertorelle R; Nardin M; Schiavi F; Iacobone M; Opocher G; Zagonel V; Zovato S
    Anticancer Drugs; 2018 Jan; 29(1):102-105. PubMed ID: 29099418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.